If you smoke, you might have to pay thousands extra for employee-based health insurance under Obamacare starting next year.
The Obama administration has outlined the essential health benefits that insurers must offer to consumers in individual and small group markets under Obamacare.
Humana said the government's proposed 2014 payment rates for Medicare participants were lower than expected and would affect its profit outlook, and its shares fell in premarket trading.
Melissa Boudreault, CGI vp of state health solutions, talks to CNBC's Bertha Coombs about the Federally-built health care exchange. She believes it will be a tremendous resource to consumers, because it must meet the needs of a number of different states.
A sharp and surprisingly persistent slowdown in the growth of health care costs is helping to narrow the federal deficit, leaving budget experts trying to figure out whether the trend will last.
U.S. regulators dealt a major blow to Novo Nordisk's hopes for its new long-acting insulin Tresiba by demanding the Danish drugmaker conduct additional clinical tests to assess potential heart risks.
Flu season is drawing attention to mandatory paid sick leave for the 40 percent of American private-sector workers — more than 40 million people — who don't have it.
New data from the CDC shows doctor visits related to the flu continued to decline last week. Robert Kelly, president of New York Presbyterian Hospital, weighs in.
This flu season is striking early, but is it really an epidemic? Tevi Troy, Romney Health Care Policy adviser, weighs in.
The big U.S. and European drug companies are dealing with their own 'cliff' as blockbuster drugs lose their patent protection. But they are turning back to research and development to fill the gap.
Making the health care system function better could save $2 trillion on health costs over the next decade, Dr. David Blumenthal, Commonwealth Fund president, told CNBC on Friday.
Widespread influenza activity has afflicted 47 states, according to the CDC. Phil Hosbach, VP of Immunization Policy, discusses whether people should be worried about dwindling supplies.
Eli Lilly will be "very challenged" by the loss of exclusivity on several blockbuster drugs, CEO John Lechleiter told CNBC on Tuesday, but added the company can manage its growth in response.
Rock bottom interest rates will likely boost key stocks in the biotechnology sector, but Obamacare will dampen prospects for HMO shares.
Peter Suderman, Reason Magazine, explains whether insurance company premiums are rising under so-called Obamacare. Meanwhile Michael Farr, Farr, Miller & Washington, discusses what that means for health stocks.
The Affordable Care Act will go far to rescue the generation hardest hit by rising health-care costs, including 8.6 million Boomers without health insurance.
States are setting up health insurance exchanges, reports CNBC's Bertha Coombs. Max Nisen, Business Insider, also weighs in.
It's hard to see how lawmakers can avoid touching health insurance if they want to eliminate loopholes and curtail deductions so as to raise revenue and lower tax rates.
Toby Cosgrove, CEO & president at The Cleveland Clinic, explains how "fiscal cliff" cuts could severely impact the health care industry.
Health care costs, especially in drug development remains high despite advancements in medicine. But as Taher Abbasi, CEO of Cellworks tells CNBC's Martin Soong, that is all set to change with innovation.